Effects of hormonal contraceptives on bone mineral density

Drug Safety

Volumn 20, Issue 3, 1999, Pages 213-222

  Cromer, Barbara A ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

BONE DENSITY; BONE MASS; BONE MINERAL; FEMALE; HUMAN; PRIORITY JOURNAL; REVIEW;

ADULT; BONE DENSITY; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVES, ORAL; FEMALE; HUMANS; LEVONORGESTREL; MEDROXYPROGESTERONE 17-ACETATE; PREMENOPAUSE; RANDOMIZED CONTROLLED TRIALS;

EID: 0033049314     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-199920030-00002     Document Type: Review

References (33)

1. Speroff L, Glass RH, Kase NG, editors. Clinical gynecologic endocrinology and infertility. 5th ed. Baltimore (MD): William and Wilkins, 1994
2. Consensus Panel. Osteoporosis, JAMA 1984; 252: 799-802
3. Delmas PD, Bjarnason NH, Mitlak BH, et al. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women. N Engl J Med 1997; 337 (23): 1641-7
4. Recker RR, Davies M, Hinders SM. Bone gain in young adult women. JAMA 1992; 268: 2403-8
5. Mazess RB, Barden HS. Bone mineral density in premenopausal women: effects of age, dietary intake, physical activity, smoking, and birth control pills. Am J Clin Nutr 1991; 53: 132-42
6. Kreipe DR, Forbes GB. Osteoporosis: a new morbidity' for dieting female adolescents? Pediatrics 1990; 86: 478-80
7. Matkovic V, Jelic T, Wardlaw GM, et al. Timing of peak hone mass in Caucasian females and its implication for the prevention of osteoporosis: inference from a cross-sectional model. J Clin Invest 1994; 93: 799-808
8. Hergenroeder AC. Bone mineralization, hypothalmic amenorrhea, and sex steroid therapy in female adolescents and young adults. J Pediatr 1995; 126: 683-9
9. Theinz G, Buchs B, Nizzolo R, et al. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992; 75: 1060-5
10. Teegarden D, Proulx WR, Martin BR, et al. Peak bone mass in young women. J Bone Miner Res 1995; 10: 711-5
11. Dhuper S, Warren MP, Brooks-Gunn J, et al. Effects of hormonal status on bone mineral density in adolescent girls. J Clin Endocrinol Metab 1990; 71: 1083-8
12. Grecu EO, Weinshelbaum A, Simmons R. Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate. Calcif Tissue Int 1990; 46: 294-9
13. Cundy T, Evans M, Roberts, et al. Bone mineral density in women receiving depot medroxyprogesterone acetate for contraception. BMJ 1991; 303: 13-9
14. Cromer BA, McArdle Blair J, Mahan JD, et al. A prospective comparison of bone mineral density in adolescent girls on depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives. J Pediatr 1996; 129: 671-6
15. Naessen T, Olson SE, Gudmundson J. Differential effects on bone mineral density of progestogen-only methods for contraception in premenopausal women. Contraception 1995; 52: 35-9
16. Scholes D, LaCroix AZ, Ichikawa L, et al. Depo-medroxyprogesterone acetate exposure and bone mineral density in young women. Annual Meeting of the American Society for Bone and Mineral Research: 1996 Sep 7-11; Seattle
17. Taneepanichskul S, Intaraprasert S, Theppisai U, et al. Bone mineral density during long-term treatment with Norplant® implants and depot medroxyprogesterone acetate: a cross-sectional study of Thai women. Contraception 1997; 56: 153-5
18. Taneepanichskul S, Intaraprasert S, Theppisai U, et al. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors. Contraception 1997; 56: 1-3
19. Mandel FP, Davidson BJ, Erlik Y, et al. Effects of progestins on bone metabolism in postmenopausal women. J Reprod Med 1982; 27 (8): 511-4
20. Gallagher JC, Kable WT, Goldgar D. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen. Am J Med 1991; 90: 171-8
21. Caird LE, Reid-Thomas V, Hannah WJ, et al. Oral progestogen-only contraception may protect against loss of bone mass in breast-feeding women. Clin Endocrinol 1994; 41: 739-45
22. Brache V, Alvarez-Sanchez F, Faundes A, et al. Ovarian endocrine function through five years of continuous treatment with Norplant® subdermal contraceptive implants. Contraception 1990; 41 (2): 169-77
23. Goldsmith NJ, Johnston JO. Bone mineral density: effects of oral contraceptives, pregnancy, and lactation. Am J Bone Joint Surg 1975; 57-A (5): 657-68
24. Shargil A. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study. Int J Fertil 1985; 30: 15-28
25. Lindsay R, Tohme J, Kanders B. The effect of oral contraceptive use on vertebral bone mass in pre- and post-menopausal women. Contraception 1986; 34: 333-40
26. Hreshchyshyn MM, Hopkins A, Zylstra S, et al. Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities. Am J Obstet Gynecol 1988; 159: 318-22
27. Lloyd T, Buchanan JR, Ursino GR, et al. Long-term oral contraceptive use does not affect trabecular bone density. Am J Obstet Gynecol 1989; 160: 402-4
28. Kleerekoper M, Brienza RS, Schultz LR, et al. Oral contraceptyive use may protect against low bone mass. Arch Intern Med 1991; 151: 1971-6
29. Rodin A, Chapman M, Ignac Fogelman. Bone density in users of combined oral contraception: preliminary reports of a pilot study. Br J Fam Plann 1991; 16: 125-9
30. Kritz-Silverstein D, Barrett-Connor E. Bone mineral density in post menopausal women as determined by prior oral contraceptive use. Am J Public Health 1993; 83: 100-2
31. Szarewski An, Hollingworth B, Guillebaud J. Depot medroxyprogesterone acetate and osteoporosis: monitor serum oestradiol concentration in users [letter]. BMJ 1994; 308: 717
32. Mehta S. Bone loss, contraception and lactation. Acta Obstet Gynecol Scand 1993; 72: 148-56
33. Cundy T, Cornish J, Evans MC, et al. Recovery of bone mineral density in women who stop using medroxyprogesterone acetate. BMJ 1993; 308: 247-8